Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 12, 2001

View Archived Issues

Management of focal spasticity is latest indication granted for Botox in Canada

GSK's Trizivir receives Health Canada approval

Genta to test Genasense in combination with docetaxel for treatment of NSCLC

Phase II results presented from AeroDose inhaled insulin study

Myriad Genetics reviews fiscal Q1 progress

Safety of AVI-4557 confirmed in phase I clinical trial

BioMarin/Ibex enzyme acquisition completed

Replicon receives grant for development of brain tumor therapies

New phase II trial of Mylovenge in conjunction with thalidomide

Wyeth Lederle Vaccines and RIVM collaborate on meningitis vaccine development

Quest Diagnostics, exclusive distributor of Vasogen's immune modulation therapy

Aripiprazole submitted for FDA review as a treatment for schizophrenia

Alteon commences phase I testing of ALT-711 in ESRD patients undergoing peritoneal dialysis

AMD-3100 rapidly mobilizes stem cells in phase I trial

Antisoma sees further progress on all fronts during the first quarter

Predictable, dose- and time-independent PK for Arixtra in young and elderly subjects

Data presented at Chest 2001 support use of tiotropium in COPD maintenance therapy

Status of Tibotec-Virco next-generation anti-HIV drugs updated in Athens

European Commission issues approval for Glivec in Bcr-Abl-positive CML

Sulfonamide glutamate receptor potentiators useful in cognitive impairment

New imidazoles for histamine H3-mediated disorders jointly identified by European labs

New series of cell adhesion inhibitors and potential uses described by Novartis

Subunit-selective GABA-A receptor agonists in development by Sanofi-Synthelabo

Wilex and Max Planck design new selective uPA inhibitors for cancer therapy

Motilin antagonists identified at Ortho-McNeil

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...